RSS Feeds
Search

Press releases

Press releases

Displaying 1..3 of 3 - per page
Order by
SGS becomes European leader in early clinical research with the acquisition of
SGS announces the acquisition of aster.cephac headquartered in Paris, France. More
Amarin Completes Target Patient Enrollment in European Phase III Trial of Miraxion™ in Huntington's Disease
Amarin Corporation plc (NASDAQ: AMRN) today announced that it has successfully completed enrollment of the 240 patients targeted for its European Phase III clinical trial of Miraxion to treat Huntington's disease (HD) ahead of schedule. More
BioXell and Lay Line Genomics announce License Agreement for Anti-TrkA Antibody against Pain
BioXell S.p.A. and Lay Line Genomics S.p.A. (LLG) today announced an exclusive, worldwide license agreement for the development of MNAC13, a novel humanized monoclonal antibody that binds to TrkA receptors, blocking the action of Nerve Growth Factor More
Displaying 1..3 of 3 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Review, Q4, 2010
Dec 2010 - 65 pages - $1,000
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Pharmaceutical Market Trends, 2007 - 2011 Key market forecasts and growth opportunities (2nd Edition)
Nov 2007 - 173 pages - $1,860
World Market for Prescription Generic Drugs, 6th Edition
Apr 2008 - 250 pages - $3,995
The Stem Cell Market Outlook
Jun 2011 - 113 pages - $3,835
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Clinical research del
Therapeutic target
Central Nervous System del
Year
2006 del

Browse By

Therapeutic target
Age-related disorders (other)
Amyotrophic lateral sclerosis
CNS (other)
Neurodegenerative disorders
Neurological
Pain
Psychiatric
Subarachnoid hemorrhage
Traumatic brain injury

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us